MSI-H / dMMR — Targeted Therapies, Trials & Pipeline

Microsatellite instability / mismatch-repair deficiency is a tumor-agnostic predictor of checkpoint-inhibitor response.

Approved drugs targeting MSI-H / dMMR

Investigational pipeline agents

Landmark trials